If you are a HCP and would like to visit the global Hemophilia website, please confirm this by pressing the button below.
This website contains information based on the Summary of Product Characteristics (SPC), as approved by the European Commission on Jivi (damoctog alfa pegol), Kovaltry (octocog alfa) and Kogenate FS (octocog alfa). It is intended to provide information to an international audience. In countries outside the EU, the local Product Information applies.
Find the list of programs & online tools for your hemophilia patients and also, learn more about Bayer's initiative towards continuous research & development in hemophilia.
Give your patients the support they need to manage their hemophilia
A step towards encouraging continous research & development in the field of hemophilia
See what Bayer is doing to help people with hemophilia to break boundaries, thrive and achieve their full potential.
© 2020 Bayer AG
This website is intended to provide information to an international audience outside the USA and UK
Last updated on 02/11/2020